Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat

Fig. 1

Immunohistochemical localization of Cy3-galcanezumab (A-E) and Cy3-bevacizumab (F) in whole mount preparations of the rat dura mater 3 days (A-C, E–F) or 30 days (D) after injection of the antibodies. Arrows indicate blood vessels, arrowheads (A-B) cells with deposition of fluorophore-labelled antibody galcanezumab. MMA: middle meningeal artery, VV: venous vessel

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us